Wegovy
This page explains the treatment, then shows provider prices, checks, delivery details, support notes and review dates where available.
Wegovy is the semaglutide brand that sits most clearly inside UK weight-management comparison. The first useful step is not just spotting a starting price, but checking how each provider handles dose progression, assessment, delivery and follow-up.
Wegovy is a weekly semaglutide route, not just a headline price
Wegovy is supplied as a once-weekly injection pen. That makes dose, delivery and ongoing provider support more important than a single low entry figure. A useful comparison keeps the full route in view, especially if the first order is only the start of treatment.
What usually changes the Wegovy decision
Dose progression
A starter dose is not the whole cost story. Compare the later strengths and the way providers explain moving through them.
Assessment style
Look for clear wording around the prescriber, health questions, previous treatment history and whether switching is supported.
Delivery and supply
Injection pens need reliable delivery handling, especially when timing and cold-chain detail matter.
Follow-up and continuity
Repeat prescribing, maintenance wording and restart rules often matter more after the first month than the opening price does.
Where Wegovy sits beside Ozempic and Rybelsus
Wegovy is the semaglutide brand most closely tied to UK weight-management comparison. Ozempic has the same active ingredient but a different brand role, while Rybelsus changes the route into a daily tablet. Keeping those distinctions clear helps prevent weak provider comparisons later.
Ozempic
Useful when the brand name is driving the search but the route still needs UK context.
Rybelsus
The oral semaglutide route, which should not be treated as a simple tablet version of Wegovy.
Wegovy vs Rybelsus
Use this if the real decision is weekly pen versus oral semaglutide.
Useful Wegovy routes on Semaglutide Compare
Semaglutide in the UK
The wider ingredient guide for brand, route and provider context.
Provider directory
Browse the providers that currently show public semaglutide detail.
Semaglutide vs tirzepatide
See the ingredient-class comparison before narrowing the shortlist further.
Semaglutide cost in the UK
Keep brand and route differences in view when comparing price signals.
Treatment next step
Move from the treatment page into route and provider checks
Treatment pages work best when they stay connected to public provider wording, route differences, listed prices and the wider semaglutide brand picture.
Source checks
MHRA Glp1 Status
MHRA/GOV.UK explains GLP-1 medicine status and safe supply channels.
Checked: 25 April 2026 Confidence: High
Source: GLP-1 medicines: what you need to know - GOV.UK / MHRA
Keep route and safety wording prominent.
NICE Semaglutide
NICE has technology appraisal guidance for semaglutide in managing overweight and obesity.
Checked: 25 April 2026 Confidence: High
Source: NICE TA875 semaglutide for managing overweight and obesity
Reviewed for NHS and treatment-setting context.